Regarding the kallikrein serine protease PSA produced by prostate cancer cells, it is able to cleave PTHrP, thus reducing bone resorption, and IGFBP3, thereby freeing up IGF-I to bind its receptor and stimulate osteoblast proliferation [72]. The gene discussed is KLK3; the disease is prostate carcinoma.